On a Mission to End Diabetes
Diabetes is the seventh-leading cause of death in the United States. The Diabetes Group at Sanford Research aims to fight this public health threat by researching type 1 and gestational diabetes.
We have a special interest in type 1 diabetes with The Sanford Project, an initiative to cure type 1 diabetes – the type that typically affects children.
We plan to end type 1 diabetes through discovery in three key areas:
- Autoimmunity: stopping the immune system’s attack on the body’s insulin-producing beta cells
- Prevention: identifying children at high risk and intervening before the onset of autoimmunity
- Regeneration: harnessing advancements in regenerative medicine to stimulate repair mechanisms and reboot insulin-producing beta cells
Our comprehensive strategy promises faster progress toward improving diabetes patients’ lives.
The Diabetes research group supports:
Primary Faculty
Secondary Faculty
Sanford Health News
-
background-image
A clue to the causes of kidney disease: It’s in your cells
Dr. Indra Chandrasekar’s team at Sanford Research uncovers new link to disease
-
background-image
NFL Alumni, Sanford Health team up on lifelong player health
NFL Alumni Health will be a resource for regenerative health and wellness
Classes & Events
-
background-image
Sanford PROMISE Community Lecture Series
Tue 03/30/21 5:30 PM - Tue 03/30/21 6:30 PM
-
background-image
Eastern South Dakota Research Symposium
Wed 06/16/21 8:00 AM - Wed 06/16/21 5:00 PM